Patients with valvular AF, severely impaired renal function, liver disease, previous major bleeding and triple therapy (simultaneous treatment with oral anticoagulation, aspirin and a P2Y12 inhibitor) were all included, therefore better reflecting the real world setting. The gene discussed is P2RY12; the disease is liver disorder.